Prologue Journal

AstraZeneca Upgrades Outlook as Cancers Drug Sales Jump

• prologu5
• 07/25/202407/25/2024

Wall Street Journal

AstraZeneca raised its full-year guidance after second-quarter earnings topped forecasts, boosted by a 15% rise in revenue at its oncology buisness.

https://www.wsj.com/articles/astrazeneca-raises-guidance-after-revenue-earnings-beat-market-expectations-20487547